1. A CD22-Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity.
- Author
-
Ballet, Romain, Brennan, Martin, Brandl, Carolin, Feng, Ningguo, Berri, Jeremy, Cheng, Julian, Ocón, Borja, Alborzian Deh Sheikh, Amin, Marki, Alex, Bi, Yuhan, Abram, Clare L, Lowell, Clifford A, Tsubata, Takeshi, Greenberg, Harry B, Macauley, Matthew S, Ley, Klaus, Nitschke, Lars, and Butcher, Eugene C
- Subjects
Intestinal Mucosa ,B-Lymphocytes ,Animals ,Mice ,Inbred BALB C ,Mice ,Inbred C57BL ,Mice ,Knockout ,Rotavirus ,Rotavirus Infections ,Disease Models ,Animal ,Integrins ,Integrin beta Chains ,Tissue Culture Techniques ,Signal Transduction ,Chemotaxis ,Leukocyte ,Endocytosis ,Immunity ,Mucosal ,Phosphorylation ,Female ,Male ,Protein Tyrosine Phosphatase ,Non-Receptor Type 6 ,Sialic Acid Binding Ig-like Lectin 2 ,1.1 Normal biological development and functioning ,Underpinning research ,Inflammatory and immune system ,Immunology - Abstract
The integrin α4β7 selectively regulates lymphocyte trafficking and adhesion in the gut and gut-associated lymphoid tissue (GALT). Here, we describe unexpected involvement of the tyrosine phosphatase Shp1 and the B cell lectin CD22 (Siglec-2) in the regulation of α4β7 surface expression and gut immunity. Shp1 selectively inhibited β7 endocytosis, enhancing surface α4β7 display and lymphocyte homing to GALT. In B cells, CD22 associated in a sialic acid-dependent manner with integrin β7 on the cell surface to target intracellular Shp1 to β7. Shp1 restrained plasma membrane β7 phosphorylation and inhibited β7 endocytosis without affecting β1 integrin. B cells with reduced Shp1 activity, lacking CD22 or expressing CD22 with mutated Shp1-binding or carbohydrate-binding domains displayed parallel reductions in surface α4β7 and in homing to GALT. Consistent with the specialized role of α4β7 in intestinal immunity, CD22 deficiency selectively inhibited intestinal antibody and pathogen responses.
- Published
- 2021